Department of Biomedical Sciences, Marquette University, Schroeder Complex 446, P.O. Box 1881, Milwaukee, WI 53201, United States.
Neurosci Lett. 2011 Jul 12;498(3):213-7. doi: 10.1016/j.neulet.2011.05.011. Epub 2011 May 11.
Fenfluramine reduces hunger and promotes body weight loss by increasing central serotonin (5-HT) signaling. More recently, neuropeptides have been linked to the regulation of feeding behavior, metabolism and body weight. To examine possible interactions between 5-HT and neuropeptides in appetite control, fenfluramine (200 nmol/0.5 μl/side) was administered directly into the hypothalamic paraventricular nuclei (PVN) of male rats. Bilateral fenfluramine produced significant hypophagia and increased expression of PVN corticotropin releasing factor (CRF) mRNA and neuropeptide Y (NPY) mRNA in the arcuate nucleus within the first hour after drug administration. Fenfluramine's effects on feeding behavior and mRNA expression were blocked by PVN injections of a 5-HT(1-2) receptor antagonist, metergoline (15 nmol/0.5 μl/side). These data suggest that 5-HT neurons targeting hypothalamic paraventricular CRF neurons may participate in an appetite control circuit for reducing food intake.
芬氟拉明通过增加中枢 5-羟色胺(5-HT)信号来减少饥饿感并促进体重减轻。最近,神经肽与进食行为、代谢和体重的调节有关。为了研究 5-HT 和神经肽在食欲控制中的可能相互作用,将芬氟拉明(200nmol/0.5μl/侧)直接注射到雄性大鼠的下丘脑室旁核(PVN)中。双侧芬氟拉明给药后 1 小时内,可显著减少食欲,并增加弓状核中促肾上腺皮质释放因子(CRF)mRNA 和神经肽 Y(NPY)mRNA 的表达。PVN 注射 5-HT(1-2)受体拮抗剂麦角乙脲(15nmol/0.5μl/侧)可阻断芬氟拉明对摄食行为和 mRNA 表达的影响。这些数据表明,靶向下丘脑室旁核 CRF 神经元的 5-HT 神经元可能参与了减少食物摄入的食欲控制回路。